Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence

被引：0
|
作者：
Chabre, Olivier [1 ]
Muller, Marie [2 ]
Cristante, Justine [1 ]
Cracowski, Jean-Luc [3 ]
Gay, Emmanuel [4 ]
机构：
[1] Univ Grenoble Alpes, CHU Grenoble Alpes, CEA,UGA, Unite Mixte Rech,Serv Endocrinol,INSERM,UMR 1036, F-38000 Grenoble, France
[2] CHU Grenoble Alpes, Serv Endocrinol, Grenoble, France
[3] Grenoble Alpes Univ, Pharmacovigilance Dept, INSERM, UMR 1300,Lab HP2, Grenoble, France
[4] Univ Grenoble Alpes, CHU Grenoble Alpes, Serv Neurochirurg, Grenoble, France
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2022年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [11] Osilodrostat - an emerging drug for the medical management of Cushing's disease
    Witek, Przemyslaw
    Mehlich, Anna
    Stasiewicz, Aleksandra
    Jawiarczyk-Przybylowska, Aleksandra
    Bolanowski, Marek
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (02) : 371 - 374
  • [12] Osilodrostat-induced adrenal insufficiency in a patient with Cushing's disease
    Ekladios, Catherine
    Khoury, Jessica
    Mehr, Shahzad
    Feghali, Krystel
    CLINICAL CASE REPORTS, 2022, 10 (11):
  • [13] Efficacy and tolerance of osilodrostat in patients with Cushing's syndrome due to adrenocortical carcinomas
    Tabarin, Antoine
    Haissaguerre, Magalie
    Lassole, Helene
    Jannin, Arnaud
    Paepegaey, Anne-Cecile
    Chabre, Olivier
    Young, Jacques
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 186 (02) : K1 - K4
  • [14] Osilodrostat for Cushing Disease and Its Role in Pediatrics
    Groselj, Urh
    Sikonja, Jaka
    Battelino, Tadej
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06): : 573 - 580
  • [15] Clinical Utility of Osilodrostat in Cushing?s Disease: Review of Currently Available Literature
    Perosevic, Milica
    Tritos, Nicholas A.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 1303 - 1312
  • [16] Aldosterone Synthase Structure With Cushing's Disease Drug Osilodrostat Provides Clues For Treatment Of Primary Aldosteronism.
    Brixius-Anderko, Simone
    Scott, Emily E.
    HYPERTENSION, 2020, 76
  • [17] Osilodrostat in Cushing's disease: The risk of delayed adrenal insufficiency should be carefully monitored
    Castinetti, Frederic
    Amodru, Vincent
    Brue, Thierry
    CLINICAL ENDOCRINOLOGY, 2023, 98 (04) : 629 - 630
  • [18] Pharmacotherapy for Cushing disease: a recent Australian experience with osilodrostat
    Fookeerah, Prishila
    McLean, Mark
    INTERNAL MEDICINE JOURNAL, 2023, 53 (03) : 451 - 452
  • [19] Response to Osilodrostat Therapy in Adrenal Cushing's Syndrome
    Stasiak, Magdalena
    Witek, Przemyslaw
    Adamska-Fita, Emilia
    Lewinski, Andrzej
    DRUG HEALTHCARE AND PATIENT SAFETY, 2024, 16 : 35 - 42
  • [20] Cushing's Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat
    Heleno, Caio Teixeira
    Hong, Seung Pyo D.
    Cho, Hyung-Gyo
    Kim, Min Jeong
    Park, Yeonggyeong
    Chae, Young Kwang
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 124 - 128
12345